NSCLC (Non-small Cell Lung Cancer)

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

Study of XB010 in Subjects With Solid Tumors

Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)

Study of Sacituzumab Tirumotecan Combined With Toripalimab for Resectable Stage II-IIIB NSCLC

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup

A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC